Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for WeLeader Biomedical Co., Ltd. (7713:TWSE), powered by AI.
WeLeader Biomedical Co., Ltd. is currently trading at $72.00. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for WeLeader Biomedical Co., Ltd. on Alpha Lenz.
View WeLeader Biomedical Co., Ltd.'s valuation metrics on Alpha Lenz.
“WeLeader Biomedical Co., Ltd.'s ROE is 19.2%. Explore profitability and growth together.”
Ask for details →WeLeader Biomedical Co., Ltd. is a Taiwan-based healthcare company specializing in the distribution and agency of in vitro diagnostic products, medical diagnostic equipment, and reagent-related services. Founded in 1992 and headquartered in Kaohsiung, the company provides a broad portfolio, including serum biochemistry integration platforms, blood gas and urine analyzers, immunoassay systems, and POCT (point-of-care testing) solutions. It supports a comprehensive range of stakeholders such as hospitals, laboratories, research institutions, and schools, offering product distribution, after-sales support, maintenance, operational coaching, and digital medical examination platforms. Market activity is primarily domestic, and the firm plays a key role in advancing automated diagnostics and integrated laboratory management within Taiwan's healthcare sector. Through its ongoing innovations in laboratory automation and medical information systems, WeLeader Biomedical is recognized as an important contributor to the efficiency and modernization of healthcare diagnostics and laboratory workflows.
“WeLeader Biomedical Co., Ltd.'s ROE is 19.2%. Explore profitability and growth together.”
Ask for details →WeLeader Biomedical Co., Ltd. (ticker: 7713) is a company listed on TWSE in the Healthcare sector (Medical Devices).
The current price is 72 with a P/E ratio of -x and P/B of -x.
ROE is 19.23% and operating margin is 23.54%. Annual revenue is $1.1B.